Associated tags: Hospital, Motion, ICU, CCHD, Carboxyhemoglobin, PVI, Premature, Oxygen saturation (medicine), Retinopathy, Uniview, DEI Holdings, Automation, Patient, News, Methemoglobin, RD, MASI, Masimo, Health
Locations: PENNSYLVANIA, US, GERMANY, ENGLAND, LONDON, SOUTH AMERICA, MIDDLE EAST, NY, PARIS, CHICAGO, LOS ANGELES, TEL AVIV, CA, SEATTLE, WA, PAKISTAN, LOUISIANA, MISSISSIPPI, BATON ROUGE, MASI, HEWLETT, BENSALEM, PA, PORTUGAL, DISTRICT OF COLUMBIA, COLORADO, BOWERS, CHILE, UNITED STATES, NORTH AMERICA, CALIFORNIA
Class Action Lawsuit,
Professional Services,
Legal,
Titan,
Masimo,
News,
Advertising,
Justice minister,
Security (finance),
Justice,
Form 10-Q,
DOJ,
MASI,
False Claims Act,
Cryptocurrency Key Points:
- WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=24978 or call Phillip Kim, Esq.
- The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
- Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
- 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.
Biotechnology,
Pharmaceutical,
Hardware,
General Health,
Health,
Medical Devices,
Health Technology,
Technology,
MASI,
Conference,
Webcast Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities Health Care Conference on Wednesday, May 15, 2024 at 4:20 p.m. Pacific Time.
Key Points:
- Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities Health Care Conference on Wednesday, May 15, 2024 at 4:20 p.m. Pacific Time.
- A live webcast of the presentation will be available on the Masimo website at www.masimo.com .
- A replay of the webcast will be available following the live presentation.
Consumer Electronics,
Technology,
Professional Services,
Managed Care,
Health,
Health Technology,
Medical Devices,
Hospitals,
Audio,
Video,
Hardware,
Finance
Technology,
FDA,
Baby,
Maternity,
Public Relations,
Investor Relations,
Communications,
Audio,
Video,
General Health,
Consumer,
Health,
Consumer Electronics,
NICU,
Humidity,
Hospital,
Skin,
OTC,
Depression,
Oxygen saturation (medicine),
PR,
Parent,
Infant,
Motion,
Skin temperature,
Perfusion,
Science,
Incidence,
Patient,
QHD,
Caregiver,
Multimedia,
MASI,
Child,
Diagnosis,
Retinopathy,
Temperature,
Medical device Alongside the FDA clearance, Masimo will make Stork’s new alarm features available to all existing and new Stork users through the Masimo Stork App, in an update scheduled to be released this summer.
Key Points:
- Alongside the FDA clearance, Masimo will make Stork’s new alarm features available to all existing and new Stork users through the Masimo Stork App, in an update scheduled to be released this summer.
- Masimo Stork is 510(k) cleared for OTC use as a wearable device intended for the monitoring of multiple physiological parameters.
- Masimo Stork is not intended to replace the monitoring, diagnosis, or treatment provided by a physician or healthcare provider.
- Masimo Stork is not intended for use with infants and neonates previously diagnosed with cardiovascular or respiratory disease or conditions.
Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024.
Key Points:
- Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024.
- The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m.
- ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
- Upon registering, each participant will be provided with details including the dial-in number and a registrant ID number.
Technology,
Medical Devices,
Hospitals,
Clinical Trials,
Health Technology,
Biotechnology,
Hardware,
Pharmaceutical,
Health,
Artificial Intelligence,
FDA,
Risk,
AI,
Halo,
Patient safety,
Patient,
Caregiver,
MASI,
Medical device Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patient Safety.
Key Points:
- Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patient Safety.
- Kiani’s speech, “Empowering Patient Safety Through AI,” will discuss how artificial intelligence-based technologies, by analyzing both historical and immediate data, can help clinicians prevent errors of omission, improving patient safety, patient outcomes, and clinician efficiency.
- We’re proud to be at the forefront of this very promising avenue of improving patient safety and patient care.
- At Masimo, we have always championed patient safety, and we’re particularly excited to collaborate with caregivers around the world to advance patient safety using AI.”
For more information about the Global Ministerial Summit, please visit psschile.minsal.cl .
Our investigation concerns whether the board of directors of Masimo have breached their fiduciary duties to the company.
Key Points:
- Our investigation concerns whether the board of directors of Masimo have breached their fiduciary duties to the company.
- Masimo’s stock price fell in response to the corrective event on July 17, 2023, as alleged supra.
- In particular, on July 17, 2023, Masimo reduced the lower end of full year revenue guidance for the healthcare business to $1.30 billion from $1.45 billion.
- The Company also announced a reduction in annual revenue guidance for the non-healthcare business to $800 million to $850 million from $965 million to $995 million.
Cardiology,
Biometrics,
Telemedicine,
Virtual Medicine,
Health,
Medical Devices,
Consumer Electronics,
Health Technology,
Technology,
CFO,
Committee,
MASI,
Patient,
Human,
Audit committee,
Bank statement,
IP,
Compensated emancipation,
COGS,
The Wall Street Journal,
Annual general meeting,
Management Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election to the Masimo Board of Directors at the company’s 2024 Annual Meeting.
Key Points:
- Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election to the Masimo Board of Directors at the company’s 2024 Annual Meeting.
- The facts undermine Mr. Koffey’s arguments and expose his willingness to mislead stockholders in pursuit of control of Masimo.
- A list of some of the documents and information Mr. Koffey has been provided is attached as Exhibit A.
- A list of the members of senior management Mr. Koffey has had discussions with is attached as Exhibit B.
Banking,
Professional Services,
Finance,
Analytical chemistry,
Biophysical environment,
Health,
Lead,
Doctor of Philosophy,
IP,
M&A,
Audit committee,
Corporate spin-off,
Audit,
WHEN,
WILL,
Science,
MASI,
Stryker Corporation,
Laboratory,
Dentsply Sirona,
Compensated emancipation,
Common stock,
Financial management,
Knowledge,
Broadcom Inc.,
Acquisition,
Security (finance),
Senior,
INC,
Avient Corporation,
Annual general meeting,
Separation,
WALL,
MIT,
Common,
Hope College,
Stanford University,
National academy,
Government,
COGS,
Management Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today announced that it is nominating two candidates for election to the Masimo Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”).
Key Points:
- Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today announced that it is nominating two candidates for election to the Masimo Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”).
- Quentin Koffey, Managing Partner and Chief Investment Officer of Politan, and a current director on the Masimo Board, stated:
“When shareholders overwhelmingly elected Michelle Brennan and me to the Masimo Board last year, we were optimistic we could work productively with the rest of the Board to drive positive change.
- However, at this stage the Board has been provided zero details, and Politan has serious concerns given the lack of basic governance and oversight we have observed since joining the Board.
- The participants in the proxy solicitation are Politan, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, Politan Capital NY LLC, Politan Intermediate Ltd., Politan Capital Partners Master Fund LP (“Politan Master Fund”), Politan Capital Partners LP (“Politan LP”), Politan Capital Offshore Partners LP (“Politan Offshore” and collectively with Politan Master Fund and Politan LP, the “Politan Funds”), Quentin Koffey, Matthew Hall, Aaron Kapito, William Jellison and Darlene Solomon (collectively, the “Participants”).
Hardware,
General Health,
Health,
Medical Devices,
Consumer Electronics,
Health Technology,
Wearables,
Mobile Technology,
Technology,
MASI,
Century,
Security (finance) Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business.
Key Points:
- Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business.
- The Board and management will evaluate the proposed structure of the separation.
- Masimo expects that the separation will include its consumer audio and consumer health products, including the Stork baby monitor and the Freedom smart watch and band.
- I proposed a separation of the consumer business in January and the Board has agreed to move forward.